Myopia can affect much more than a child's ability to see clearly. It influences how they experience everyday activities, from reading the whiteboard in class and playing sports to recognising faces and seeing road signs in the distance.
When a child’s myopia continues to worsen year after year, many parents wonder whether standard lenses are enough. While regular spectacles can correct blurry distance vision, they do not typically address the underlying progression of myopia. As myopia increases, so does the likelihood of requiring stronger prescriptions and the potential for future eye health concerns.
Fortunately, advancements in myopia management have given parents more options than ever before. These include orthokeratology (Ortho-K), atropine eye drops, and specialised myopia management spectacle lenses. Among these options, spectacle lenses are often considered one of the most convenient and child-friendly solutions. They are easy to wear, non-invasive, and can help children enjoy clear vision while supporting long-term myopia management.
What a myopia management spectacle lens does
Most children with myopia start with single vision lenses, which help them see clearly in everyday life. But as myopia can continue to progress throughout childhood, many parents are now exploring lenses that do more than correct blurry vision.
Myopia management lenses are designed to provide clear sight while helping to slow myopia progression. They do not only correct the child's vision today, they support their long-term visual development.
Single vision lenses: the starting point for many wearers
Single vision lenses have long been the standard approach to correcting myopia. They provide a consistent prescription across the entire lens surface, so the child sees clearly at every distance. That is the job they were designed to do, and they do it well.
What they do not do is influence how the myopia progresses. Myopia often progresses as children grow and develop, and for a child whose prescription keeps changing, correction alone leaves the underlying issue unaddressed. That is when a family may need to look at options that go beyond basic correction.
Why lens material matters too
The prescription is only part of the decision. Lens material affects how the glasses feel, how they look, and how likely a child is to wear them consistently. For parents and families, that matters because the best lens on paper does very little if the child leaves it on the desk.
Lens materials come in a range of options, from thinner high-index lenses to impact-resistant choices. In practical terms, that can mean a lighter pair of glasses, a slimmer look, or a stronger lens for active wear.
MiYOSMART iQ also comes with S.P.A.R.K. coating, which offers up to 50% greater scratch resistance compared to the previous generation,¹⁴ resists smudges, dust and water,¹³˒¹⁴ and blocks 100% of harmful UV rays from the front.¹⁴ It is designed with active children in mind.
Common factors families notice
When choosing a lens, families often care about:
- Weight
- Thickness
- Durability
- Comfort
- Appearance
Those points matter more than many people expect. A child who feels comfortable in their glasses is more likely to wear them properly, and that makes a real difference in daily life for the whole family.
MiYOSMART iQ as a myopia management option
Single vision lenses correct blurry distance vision. MiYOSMART lenses correct it too, and work on the progression at the same time. That is the difference, and for a child whose prescription keeps changing, it is the one that matters.
MiYOSMART is HOYA's myopia management lens for children, available in over 50 countries worldwide.⁴ MiYOSMART iQ is the current generation.
MiYOSMART iQ spectacle lenses are the innovative solution for controlling myopia progression in an easy, safe, effective and non-invasive way.¹˒² They have been shown to stop myopia progression*, on average, in the first 12 months of wear.¹˒²
For families, nothing about the experience changes. The child wears an ordinary-looking pair of glasses to school, to sport, and everywhere else. The lens simply does more than the last pair did.
How MiYOSMART iQ works in simple terms
Building on the proven D.I.M.S. Technology, MiYOSMART iQ incorporates a Triple Enhanced Design developed to enable effective myopia control in children. The design brings the treatment area closer to the geometrical centre of the lens, delivers a stronger myopic defocus signal, and extends coverage across the spectacle lens.⁵˒⁶˒⁷
That balance is the point. The lens corrects the child's vision today, the way any pair of glasses would, and works on the progression over the years ahead. One pair, two jobs.
Who may consider MiYOSMART iQ
MiYOSMART iQ is worth discussing when:
- A child's myopia is progressing
- The family wants a non-invasive option for managing that progression
- Clear distance vision matters now, and managing progression matters for the long term
- Compliance and everyday wear matter
Every child is different, so the right choice depends on the prescription, age, lifestyle, and advice from an eye care professional.
MiYOSMART iQ is available in two options. MiYOSMART iQ Clear looks just like a standard single vision spectacle lens.² MiYOSMART iQ Chameleon offers the same myopia control with photochromic technology that darkens when exposed to UV (sunlight), for children who move between indoors and outdoors during the day.
Why evidence matters in myopia care
Myopia management is not something to approach casually. Children can go through frequent prescription changes, and those changes can affect comfort, confidence, and how well they function day to day. A research-backed option gives parents more confidence when they are making a decision that may affect years of eye care.
What the research says
Parents often want more than product claims. That is fair. If a lens is being considered for a child, the evidence behind it matters.
MiYOSMART iQ has been evaluated in a randomised controlled clinical trial in children aged 4 to 12 years.¹˒⁸ With 9 out of 10 children showing no clinically relevant myopia progression* in the first 12 months of wear,¹˒² and D.I.M.S. Technology backed by more than 100 scientific publications,⁴ the research gives parents and families a stronger basis for discussion with their eye care professional.
MiYOSMART iQ is HOYA's first spectacle lens with reported clinical evidence for effective control of myopia progression from the age of 4 years, as a monotherapy.¹˒²˒⁸
A simple comparison of lens options for myopia
|
Lens option |
Main purpose |
Best suited for |
Clinical evidence for myopia management |
|
Single vision lens |
Corrects distance blur only |
Far distance correction |
None |
|
MiYOSMART iQ |
Corrects vision and supports myopia management using Triple Enhanced D.I.M.S. Technology |
Children aged 4 to 12 with progressing myopia |
Evaluated in a randomised controlled clinical trial in children aged 4 to 12 years¹˒⁸ |
How to choose the right option
There is no single lens that works for every child. The best choice depends on the child’s visual needs and the family’s daily routine.
1. Look at how fast the myopia is changing
If the prescription keeps changing, that can be a sign that more than simple correction is needed. In that case, a myopia management lens may be part of the conversation.
2. Think about comfort and wear time
Children need glasses they will actually wear. A lens that feels too heavy or too thick may quickly become a problem. Comfort affects wearer compliance, which is simply whether the glasses stay on through a full school day.
3. Match the lens to the lifestyle
Some children are active all day and need a lens that can keep up. Others may need a lens that works well for school, reading, and screen time. The right lens should support the child’s routine, not get in the way of it.
4. Choose the lens material carefully
Two lenses with the same prescription can feel very different depending on the material. A thinner, lighter material makes a real difference for stronger prescriptions, and an impact-resistant material suits children who are hard on their glasses.
5. Ask for professional advice
This is not a decision families need to make alone. Eye Care Professionals can explain whether a child would be better suited to a standard single vision lens or a myopia management option like MiYOSMART iQ.
You can use our find an optician page to locate an eye care professional who can help with that discussion.
Why guidance from eye care professionals matters
Myopia care works best when the family and Eye Care Professional are working from the same plan. That plan should take prescription history, age, daily habits, and overall eye health into account.
When single vision is enough, and when it may not be
Single vision lenses still have an important place. They are often the right starting point, especially when myopia is mild or stable.
But if myopia is progressing, a standard lens may not be enough on its own. That is when parents and families may start thinking differently. The question changes from “Can my child see clearly?” to “Can we also help manage the myopia over time?”
That is the point where a lens like MiYOSMART iQ can become part of the discussion.
Practical points families should remember
A good myopia lens choice should be:
- Clear enough for daily life
- Comfortable enough to wear consistently
- Suited to the child’s prescription
- Matched to the child’s activity level
- Supported by proper professional advice
- Support long term myopia therapy to manage progression
That is the balance parents and families are usually trying to find.
Conclusion
Myopia spectacle lens options now go beyond standard correction alone. Single vision lenses still have a clear role, especially when the need is basic distance vision correction. But for children aged 4 to 12 whose myopia is progressing, MiYOSMART iQ offers a spectacle lens approach designed to support both clear vision and myopia management, backed by clinical evidence showing 9 out of 10 children showed no clinically relevant myopia progression* in the first 12 months of wear.¹˒²
The best choice depends on the child, the prescription, and the guidance of an eye care professional. Lens material, comfort and wearer compliance also matter because a lens only helps when it is worn properly.
For more information about HOYA Australia and our lens solutions, visit HOYA Australia.
- Tse D.Y., Hon Y., Chun R. K., Leung T. W., Leung D. K. Y., To C. H., Lam C SY. Myopia Control Efficacy of Defocus Incorporated Multiple Segments Spectacle lens with Triple Enhanced Design: 12-month randomized controlled trial. Abstract 2523, ARVO 2026 Annual Meeting, Denver, USA. https://eppro02.ativ.me/web/index.php?page=IntHtml&project=ARVO26&id=4486941
- HOYA data on file. HOYA MiYOSMART iQ spectacle lens clinical outcomes. 04/2026.
- Based on the number of publications in peer-reviewed journals as of July 2026.
- HOYA data on file. MiYOSMART spectacle lens commercial data. 04/2026.
- Smith III EL, Arumugam B, Hung LF, et al. Eccentricity-dependent effects of simultaneous competing defocus on emmetropization in infant rhesus monkeys. Vision Res. 2020;177:32-40. https://doi.org/10.1016/j.visres.2020.08.003
- Panorgias A, Aigbe S, Jeong E, et al. Retinal Responses to Simulated Optical Blur Using a Novel Dead Leaves ERG Stimulus. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):1.
- Swiatczak B, Scholl HPN, Schaeffel F. Retinal "sweet spot" for myopia treatment. Sci Rep 14, 26773 (2024). https://doi.org/10.1038/s41598-024-78300-x
- Tse DYY, Chun RKM, Hon Y, et al. Myopia Control Efficacy of Defocus Incorporated Multiple Segments Triple Enhanced Design Spectacle Lenses. The 41st Asia-Pacific Academy of Ophthalmology Congress, 2026. https://2026.apaophth.org/abstract/?code=205567
- Eyewear Market Size, Share and Trends Analysis Report. Grand View Research, 2025. https://www.grandviewresearch.com/industry-analysis/eyewear-industry
- HOYA data on file. MiYOSMART iQ TF spectacle lens technical data. 04/2026.
- HOYA data on file. Myopia Control Efficacy of Second-generation Defocus Incorporated Multiple Segments Spectacle Lenses on Fast Progressing Myopes: A Randomised Controlled Trial: Summary of 12-month analysis on complete cases. 01/2026.
- HOYA data on file. MiYOSMART iQ S.P.A.R.K. coating technical results. 05/2026.
- HOYA data on file. Product assessment report - STX MiYOSMART Green PAR. 06/2025.
- HOYA data on file. MiYOSMART iQ S.P.A.R.K. coating technical data. 04/2026. Compliance with ISO 8980-3:2022.
- Vlasak N. et al. Eight years of performance of defocus incorporated multiple segments (DIMS) spectacle lenses: User experience and myopia management outcomes. Rapid Fire Session VII: Myopia. EAOO 2025, Ljubljana, Slovenia.